S
ETNB

SignatureFD’s 89bio ETNB Stock Holding History

SignatureFD’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-309
Closed -$4.54K – 3449
2025
Q3 		$4.54K Hold
309
– – ﹤0.01% 2709
2025
Q2 		$3.03K Buy
309
+112
+57% +$927 ﹤0.01% 2748
2025
Q1 		$1.43K Hold
197
– – ﹤0.01% 2964
2024
Q4 		$1.54K Sell
197
-15
-7% -$124 ﹤0.01% 2942
2024
Q3 		$1.57K Buy
212
+92
+77% +$774 ﹤0.01% 2892
2024
Q2 		$961 Sell
120
-286
-70% -$2.55K ﹤0.01% 2910
2024
Q1 		$4.73K Buy
406
+182
+81% +$2.02K ﹤0.01% 2556
2023
Q4 		$2.5K Buy
224
+177
+377% +$1.63K ﹤0.01% 2708
2023
Q3 		$726 Sell
47
-72
-61% -$1.21K ﹤0.01% 2979
2023
Q2 		$2.25K Buy
119
+72
+153% +$1.26K ﹤0.01% 2770
2023
Q1 		$716 Sell
47
-92
-66% -$1.2K ﹤0.01% 3047
2022
Q4 		$1.77K Buy
+139
New +$1.25K ﹤0.01% 2850

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SignatureFD's ETNB Position: Q4 2025 in Review

SignatureFD sold out of 89bio (ETNB) in Q4 2025, closing a stake of 309 shares — an estimated $4.54K sold.

SignatureFD first reported a position in ETNB in Q4 2022 and held it in 12 quarters. The position peaked at $4.73K in Q1 2024. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • SignatureFD reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • SignatureFD sold 309 89bio shares in Q4 2025, an estimated $4.54K.
  • SignatureFD first reported a position in 89bio in Q4 2022 and held it in 12 quarters.
  • SignatureFD's 89bio position peaked at $4.73K in Q1 2024.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on SignatureFD's 13F filing for Q4 2025, filed 20 Jan 2026.